Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating complement mediated diseases with fusion protein constructs comprising anti-C3d antibody and a complement modulator

Methods of treating complement mediated diseases with fusion protein constructs comprising anti-C3d antibody and a complement modulator

US Patent 11879008 · Granted Jan 23, 2024

Estimated economic value: $716,000 ⓘ

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

WRN inhibitors2025
WRN inhibitors2025
Modulation of gene transcription using antisense oligonucleotides targeting regu2025
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inh2025
Inhibiting deubiquitinase USP25 and USP282025
Carboxamides as ubiquitin-specific protease inhibitors2024
Purinones as ubiquitin-specific protease 1 inhibitors2024
Anti-VLA-4 antibodies having reduced effector function2024
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors2024
Humanized anti-complement factor Bb antibodies and uses thereof2024
Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors2023
Anti-VLA-4 antibodies2023